Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 626 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06681207Recruiting
Exploring brain stimulation for stepping after stroke
This study tests whether a mild electrical brain stimulation can help people with chronic stroke improve their stepping and walking. If you have had a stroke at least 6 months ago, can walk with or without a device, and have some leg weakness, this study may be for you.
Galveston, TexasAges 21–90 - NCT06682650Recruiting
Colorectal cancer screening tool for Spanish-speaking communities
This study tests if a new tool can help clinics in Spanish-speaking communities get more people screened for colorectal cancer. If you are an adult 45–75 who is due for screening and get care at a participating clinic, you may be eligible.
Aurora, ColoradoAges 45–75 - NCT06693661Recruiting
Learning to improve kidney care for Black patients
This study tests a program to help Black patients with advanced kidney disease learn about their condition and treatment options. It aims to see if this learning program can improve health outcomes.
Atlanta, GeorgiaAges 18 years+ - NCT06703606RecruitingPhase 1
Switching from Emicizumab to Marstacimab for Severe Hemophilia A
This study tests if switching from emicizumab to a new medicine called marstacimab is safe and effective for people with severe hemophilia A. You must have been on emicizumab for at least 6 months and not have a history of blood clots or heart disease.
Los Angeles, CaliforniaAges 12–74 - NCT05689151Recruiting
Abrocitinib for adult moderate to severe atopic eczema
This study tests how well abrocitinib (a prescription medicine) works for adults with moderate to severe atopic dermatitis (atopic eczema). You may join if you meet the study’s health and consent requirements and your doctor believes abrocitinib is an appropriate option for you.
Amiens, SommeAges 18 years+ - NCT07063901Recruiting
Predicting esophageal cancer treatment response with AI and imaging
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
Changsha, HunanAges Any age - NCT07290036RecruitingPhase 1
Testing different ways to give bimekizumab for psoriatic arthritis or axial spondyloarthritis
This study looks at whether giving bimekizumab in different ways is safe and how it moves through the body over time. It is for adults with active psoriatic arthritis or axial spondyloarthritis who may benefit from bimekizumab treatment.
Peoria, ArizonaAges 18 years+ - NCT07226115Recruiting
Predicting chemotherapy outcomes for colorectal cancer
This trial uses a special test on your tumor tissue to see if it can predict how well chemotherapy will work for you. If you have had chemotherapy for stage II or III colorectal cancer after surgery, your stored tumor sample may help develop a tool that could guide future treatment decisions.
Duarte, CaliforniaAges 18–80 - NCT07227415RecruitingPhase 1/Phase 2
Study of a new drug for advanced kidney cancer
This trial tests a new drug, PF-08634404, alone or with other cancer treatments, for adults with advanced kidney cancer that has not been treated before. It aims to see if the drug can help shrink tumors or stop them from growing.
Phoenix, ArizonaAges 18 years+ - NCT07406282Recruiting
Darolutamide for new prostate cancer that spread
This study looks at how well darolutamide and similar drugs work for men whose prostate cancer has just spread to other parts of the body. It aims to understand real-world outcomes in urology clinics.
Cleveland, OhioAges 18 years+ - NCT06714474Recruiting
Virtual game for teaching blood draw skills to nursing students
This trial tests if a virtual simulation game helps nursing students learn how to draw blood from a vein. It may offer a new way to practice this skill before working with real patients.
Izmir, İzmirAges 18 years+ - NCT06727253Recruiting
Glycan supplement study for Crohn's disease after surgery
This trial tests whether a glycan supplement can prevent Crohn's disease from coming back after surgery to remove the diseased part of the small and large intestine. It may help people who have had this specific surgery and are not taking certain other treatments.
Lisbon, Lisbon DistrictAges 18–75 - NCT06735118Recruiting
Can AI help see chemo-related fatty liver?
This study uses a special MRI technique and artificial intelligence to see how chemotherapy may cause a fatty liver. It may help find liver changes early in people who have had chemo.
Kunming, YunnanAges 18–80 - NCT06760819RecruitingPhase 2
Sevacertinib for solid tumors with HER2 mutations
This study tests an oral tablet called sevacertinib in people with solid tumors (not lung cancer) that have a HER2 mutation. It aims to see how well the drug works and how safe it is for people who have tried other treatments or have no good options left.
Birmingham, AlabamaAges 18 years+ - NCT06765642Recruiting
Brain stimulation for hand strength after stroke
This study tests whether a safe, non-invasive brain stimulation technique (called rTMS) can improve hand strength and movement in people who have had a stroke at least 3 months ago. The treatment is delivered through a coil placed on the scalp and does not require surgery.
Durham, North CarolinaAges 21 years+ - NCT06767254Recruiting
Using AI to predict early return of multiple myeloma
This study uses artificial intelligence to analyze how multiple myeloma may lead to early relapse. It may help doctors better predict and manage the disease.
Meldola, Forlì-CesenaAges 18 years+ - NCT06773598Recruiting
MRI-based machine learning tool for prostate cancer
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
BolognaAges 18 years+ - NCT06779773Recruiting
Study of avacincaptad pegol (Izervay) for geographic atrophy
This study looks at how avacincaptad pegol (brand name Izervay) works in real-world medical practice for people with geographic atrophy, a form of age-related macular degeneration that causes vision loss. If your doctor has already decided to treat you with this medicine, you may be able to join.
Phoenix, ArizonaAges Any age - NCT06780501Recruiting
Database for people with intellectual disabilities and epilepsy
This trial creates a database of health information from people with intellectual disabilities and epilepsy. It aims to help doctors and researchers learn more about these conditions and improve care. The database includes information from medical records, and some people may also be asked to join a research register for future studies.
BodminAges 18 years+ - NCT06806163Recruiting
Preventing Opioid Overdoses with Smart Reminders
This study tests whether a computer program can help doctors and patients have a conversation about safe opioid use. It uses information from your medical records to send reminders to your doctor, aiming to prevent overdoses.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06815250Recruiting
Boosting maternal vaccine knowledge and uptake: The InTroDuce-Programme
This trial tests a programme to help pregnant women learn about and get flu and Tdap vaccines. It aims to increase vaccination rates and improve health for mothers and babies.
Bandar Baru Bangi, SelangorAges 18 years+ - NCT06819618Recruiting
Predicting heart failure outcomes with machine learning
This trial uses machine learning to analyze data from a smartwatch to predict how heart failure progresses. It may help doctors better understand your condition and tailor treatments.
Goettigen, Lower SaxonyAges 18 years+ - NCT06829147Recruiting
AI to diagnose lymph node spread in nasopharyngeal cancer
This trial tests whether a computer model can accurately detect if cancer has spread to lymph nodes in patients with nasopharyngeal carcinoma. It uses MRI and PET/CT scans taken before treatment to see if the AI can replace or supplement current methods.
Guangzhou, GuangdongAges Any age - NCT06835569RecruitingPhase 1
ALTA3263 for advanced KRAS-mutated solid tumors
This trial tests an experimental pill called ALTA3263 for adults with advanced solid tumors that have a specific KRAS mutation. It's for people who have already tried other treatments or can't take them.
Orlando, FloridaAges 18 years+
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 626 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.